Literature DB >> 31386104

Palliative Care for people living with heart failure - European Association for Palliative Care Task Force expert position statement.

Piotr Z Sobanski1, Bernd Alt-Epping2, David C Currow3,4, Sarah J Goodlin5, Tomasz Grodzicki6, Karen Hogg7, Daisy J A Janssen8,9, Miriam J Johnson10, Malgorzata Krajnik11, Carlo Leget12, Manuel Martínez-Sellés13, Matteo Moroni14, Paul S Mueller15, Mary Ryder16, Steffen T Simon17,18, Emily Stowe19, Philip J Larkin20,21.   

Abstract

Contrary to common perception, modern palliative care (PC) is applicable to all people with an incurable disease, not only cancer. PC is appropriate at every stage of disease progression, when PC needs emerge. These needs can be of physical, emotional, social or spiritual nature. This document encourages the use of validated assessment tools to recognise such needs and ascertain efficacy of management. PC interventions should be provided alongside cardiologic management. Treating breathlessness is more effective, when cardiologic management is supported by PC interventions. Treating other symptoms like pain or depression requires predominantly PC interventions. Advance Care Planning aims to ensure that the future treatment and care the person receives is concordant with their personal values and goals, even after losing decision-making capacity. It should include also disease specific aspects, such as modification of implantable device activity at the end of life. The Whole Person Care concept describes the inseparability of the physical, emotional and spiritual dimensions of the human being. Addressing psychological and spiritual needs, together with medical treatment, maintains personal integrity and promotes emotional healing. Most PC concerns can be addressed by the usual care team, supported by a PC specialist if needed. During dying, the persons' needs may change dynamically and intensive PC is often required. Following the death of a person, bereavement services benefit loved ones. The authors conclude that the inclusion of PC within the regular clinical framework for people with heart failure results in a substantial improvement in quality of life as well as comfort and dignity whilst dying.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  heart failure; palliative care

Year:  2019        PMID: 31386104     DOI: 10.1093/cvr/cvz200

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  31 in total

1.  Referral Criteria to Palliative Care for Patients With Heart Failure: A Systematic Review.

Authors:  Yuchieh Kathryn Chang; Holland Kaplan; Yimin Geng; Li Mo; Jennifer Philip; Anna Collins; Larry A Allen; John A McClung; Martin A Denvir; David Hui
Journal:  Circ Heart Fail       Date:  2020-09-09       Impact factor: 8.790

2.  Race Differences in Quality of Life following a Palliative Care Intervention in Patients with Advanced Heart Failure: Insights from the Palliative Care in Heart Failure Trial.

Authors:  Rachel S Tobin; Marc D Samsky; Maragatha Kuchibhatla; Christopher M O'Connor; Mona Fiuzat; Haider J Warraich; Kevin J Anstrom; Bradi B Granger; Daniel B Mark; James A Tulsky; Joseph G Rogers; Robert J Mentz; Kimberly S Johnson
Journal:  J Palliat Med       Date:  2021-12-01       Impact factor: 2.947

3.  Comprehensive symptom assessment using Integrated Palliative care Outcome Scale in hospitalized heart failure patients.

Authors:  Yasuhiro Hamatani; Moritake Iguchi; Yurika Ikeyama; Atsuko Kunugida; Megumi Ogawa; Natsushige Yasuda; Kana Fujimoto; Hidenori Ichihara; Misaki Sakai; Tae Kinoshita; Yasuyo Nakashima; Masaharu Akao
Journal:  ESC Heart Fail       Date:  2022-03-20

4.  Effect of an Early Palliative Care Telehealth Intervention vs Usual Care on Patients With Heart Failure: The ENABLE CHF-PC Randomized Clinical Trial.

Authors:  Marie A Bakitas; J Nicholas Dionne-Odom; Deborah B Ejem; Rachel Wells; Andres Azuero; Macy L Stockdill; Konda Keebler; Elizabeth Sockwell; Sheri Tims; Sally Engler; Karen Steinhauser; Elizabeth Kvale; Raegan W Durant; Rodney O Tucker; Kathryn L Burgio; Jose Tallaj; Keith M Swetz; Salpy V Pamboukian
Journal:  JAMA Intern Med       Date:  2020-09-01       Impact factor: 21.873

5.  Palliative care in pulmonary hypertension associated with congenital heart disease: systematic review and expert opinion.

Authors:  Andrew Constantine; Robin Condliffe; Paul Clift; Robert Tulloh; Konstantinos Dimopoulos
Journal:  ESC Heart Fail       Date:  2021-03-03

6.  Comprehensive Palliative Care Needs in Outpatients with Chronic Heart Failure: A Japanese Cross-Sectional Study.

Authors:  Ryo Matsunuma; Kensuke Matsumoto; Takashi Yamaguchi; Akihiro Sakashita; Yoshiyuki Kizawa
Journal:  Palliat Med Rep       Date:  2022-04-18

7.  Unmet device reprogramming needs at the end of life among patients with implantable cardioverter defibrillator: A systematic review and meta-analysis.

Authors:  Valentina Gonzalez-Jaramillo; Piotr Sobanski; Jose A Calvache; Luisa F Arenas-Ochoa; Oscar H Franco; Lukas Hunziker; Steffen Eychmüller; Maud Maessen
Journal:  Palliat Med       Date:  2020-06-26       Impact factor: 4.762

8.  A comparative study on decision and documentation of refraining from resuscitation in two medical home care units in Sweden.

Authors:  Bogdan Sterpu; Pia Lindman; Linda Björkhem-Bergman
Journal:  BMC Palliat Care       Date:  2019-10-17       Impact factor: 3.234

Review 9.  Ethical Issues in Decision-making Regarding the Elderly Affected by Coronavirus Disease 2019: An Expert Opinion.

Authors:  David Martínez-Sellés; Helena Martínez-Sellés; Manuel Martinez-Sellés
Journal:  Eur Cardiol       Date:  2020-05-18

10.  Tools to help healthcare professionals recognize palliative care needs in patients with advanced heart failure: A systematic review.

Authors:  Stephanie Mc Ament; Inge Me Couwenberg; Josiane Jj Boyne; Jos Kleijnen; Henri Ejh Stoffers; Marieke Hj van den Beuken; Yvonne Engels; Louise Bellersen; Daisy Ja Janssen
Journal:  Palliat Med       Date:  2020-10-15       Impact factor: 4.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.